Recent data on hypertension and progressive renal disease.

Abstract

Arterial hypertension may favour the progression of non-diabetic primary renal disease and participate in the appearance of atheromatous renovascular disease. In AIPRI trial (ACE-inhibition in the progression of renal insufficiency) the ACE-inhibitor benazepril was able to protect patients with mild-to-moderate renal disease against the progression of renal insufficiency. Some clinical observations suggest that in many aged patients with long-standing hypertension the appearance of renal failure may be related to atheromatous reno-vascular disease. This disease may be responsible for progressive renal failure through renal artery stenosis and/or cholesterol microembolization.

• Authors: P Zucchelli, A Zuccalà
• Journal: Journal of human hypertension (J Hum Hypertens) Vol. 10 Issue 10 Pg. 679-82 (Oct 1996) ISSN: 0950-9240 [Print] England
• PMID: 9004094 (Publication Type: Journal Article, Review)

Topics

• Disease Progression
• Humans
• Hypertension (complications, drug therapy)
• Renal Insufficiency (drug therapy, etiology)